USD 2.33
(14.22%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 8.93 Million | 18.62 Million | 14.35 Million | 10.76 Million |
Cost of Revenue | 9.88 Million | 16.95 Million | 12.17 Million | 9.73 Million |
Gross Profit | -948.87 Thousand | 1.66 Million | 2.18 Million | 1.03 Million |
Operating Expenses | 5.08 Million | 3.44 Million | 659.87 Thousand | 384.2 Thousand |
Selling, General and Administrative Expenses | 4.06 Million | 3.44 Million | 659.87 Thousand | 384.2 Thousand |
Research and Development Expenses | - | - | - | - |
Other Expenses | 1.02 Million | 27.4 Thousand | 56.79 Thousand | 6707.00 |
Cost and Expenses | 14.97 Million | 20.39 Million | 12.83 Million | 10.11 Million |
Operating Income | -6.03 Million | -1.77 Million | 1.52 Million | 648.94 Thousand |
Interest Expense | 847.19 Thousand | 742.71 Thousand | 1056.00 | - |
Income Tax Expense | 218.35 Thousand | -68.44 Thousand | 441.78 Thousand | 190.67 Thousand |
Earnings before Tax | -7.11 Million | -2.52 Million | 1.57 Million | 655.65 Thousand |
Net Income | -7.33 Million | -2.46 Million | 1.13 Million | 464.97 Thousand |
Earnings Per Share Basic | -0.33 | -0.15 | 0.05 | 0.02 |
Earnings Per Share Diluted | -0.33 | -0.15 | 0.05 | 0.02 |
Weighted Average Shares Outstanding | 22.27 Million | 16.7 Million | 22.27 Million | 22.27 Million |
Weighted Average Shares Outstanding (Diluted) | 22.27 Million | 16.7 Million | 22.27 Million | 22.27 Million |
Gross Margin | -0.11 | 0.09 | 0.15 | 0.10 |
EBIT Margin | -0.64 | -0.07 | 0.12 | 0.06 |
Profit Margin | -0.82 | -0.13 | 0.08 | 0.04 |
EBITDA | -5.73 Million | -1.36 Million | 1.7 Million | 678.63 Thousand |
Earnings Before Tax Margin | -0.68 | -0.10 | 0.11 | 0.06 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 3.4 Million | 2.2 Million | 1.33 Million | 8.93 Million | 2.69 Million | 1.94 Million |
Cost of Revenue | 2.95 Million | 1.89 Million | 2.83 Million | 9.88 Million | 2.53 Million | 1.84 Million |
Gross Profit | 452.22 Thousand | 312.31 Thousand | -1.5 Million | -948.87 Thousand | 158.76 Thousand | 100.27 Thousand |
Operating Expenses | 1.73 Million | 1.31 Million | 2.47 Million | 4.06 Million | 579.82 Thousand | 458.03 Thousand |
Selling, General and Administrative Expenses | 1.73 Million | 1.31 Million | 2.47 Million | - | 579.82 Thousand | 458.03 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 3738.00 | - | -2075.00 | -752.00 | -5023.00 | 6716.00 |
Cost and Expenses | 4.68 Million | 3.2 Million | 5.3 Million | 13.94 Million | 3.11 Million | 2.3 Million |
Operating Income | -1.28 Million | -1 Million | -4.99 Million | -6.03 Million | -421.05 Thousand | -357.76 Thousand |
Interest Expense | 486.58 Thousand | 302.38 Thousand | 354.12 Thousand | 847.19 Thousand | 133.04 Thousand | -38.89 Thousand |
Income Tax Expense | 800.00 | 1700.00 | 604.21 Thousand | 218.35 Thousand | -155.16 Thousand | -139.04 Thousand |
Earnings before Tax | -1.76 Million | -2.3 Million | -5.35 Million | -7.11 Million | -559.12 Thousand | -545.61 Thousand |
Net Income | -1.76 Million | -2.3 Million | -5.96 Million | -7.33 Million | -403.96 Thousand | -406.57 Thousand |
Earnings Per Share Basic | -0.07 | -0.10 | -0.33 | - | -0.07 | -0.07 |
Earnings Per Share Diluted | -0.07 | -0.10 | -0.33 | - | -0.07 | -0.07 |
Weighted Average Shares Outstanding | 26.41 Million | 23.17 Million | 18.28 Million | 22.27 Million | 5.72 Million | 5.72 Million |
Weighted Average Shares Outstanding (Diluted) | 26.41 Million | 23.17 Million | 18.28 Million | 22.27 Million | 5.72 Million | 5.72 Million |
Gross Margin | 0.13 | 0.14 | -1.13 | -0.11 | 0.06 | 0.05 |
EBIT Margin | -0.34 | -0.86 | -2.89 | - | -0.11 | -0.23 |
Profit Margin | -0.52 | -1.05 | -4.48 | -0.82 | -0.15 | -0.21 |
EBITDA | -1.14 Million | -1.9 Million | -3.85 Million | - | -301.58 Thousand | -449.84 Thousand |
Earnings Before Tax Margin | -0.38 | -0.45 | -3.75 | -0.68 | -0.16 | -0.18 |
BMED
NGEX
300232
0JZ2
DGR
300252